Table 1.
Demographic characteristics of kidney transplant recipients and donors.
| Recipients | |
|---|---|
| Gender (male) | 178 (69.5) |
| Age (years), median (IQR) | 41 (34-50) |
| BMI, median (IQR) | 22.59 (20.21-24.82) |
| Postoperative day (IQR) | 16 (10-32) |
| Comorbidity, n (%) | |
| Hypertension | 187 (73.0) |
| Anemia | 117 (45.7) |
| Hepatitis B | 14 (5.5) |
| Diabetes | 12 (4.7) |
| Anterolisthesis | 6 (2.3) |
| Coronary heart disease | 4 (1.6) |
| Others Laboratory findingsa, median (IQR) |
4 (1.6) |
| White blood cell count (×109/L) | 6.92 (5.2-9.03) |
| Red blood cell count (×109/L) | 3.02 (2.59-3.53) |
| Hemoglobin (g/L) | 91.0 (79.0-105.0) |
| Hematocrit (%) | 27.2 (23.5-32.0) |
| Platelet count (×109/L) | 179.0 (142.0-230.0) |
| Neutrophil count (×109/L) | 5.34 (3.87-7.24) |
| Total bilirubin (μmol/L) | 8.4 (6.5-11.17) |
| ALT (U/L) | 26.0 (17.0-37.0) |
| AST (U/L) | 16.0 (13.0-20.0) |
| ALP (U/L) | 62.0 (47.0-82.0) |
| TP (g/L) | 62.1 (57.02-69) |
| ALB (g/L) | 39.0 (34.9-43.5) |
| BUN (mmol/L) | 10.84 (7.62-16.97) |
| Cre (μmol/L) | 835.3 (700.75-916.78) |
| Uric acid (μmol/L) | 325.1 (253.45-411.6) |
| Immunosuppression regimens | |
| Induction agent, n (%) | |
| Basiliximab | 32 (12.5) |
| Antithymocyte globulin | 224 (87.5) |
| Antiproliferative agent, n (%) | |
| Mycophenolate | 239 (93.4) |
| Azathioprine | 17 (6.6) |
| Donors | |
| Gender (male) | 175 (68.4) |
| Age (years), median (IQR) | 49 (37-59) |
| BMI, median (IQR) | 24.2 (21.5-29.6) |
aThe first day after kidney transplantation. BMI: body mass index; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; TP: total protein; ALB: albumin; BUN: blood urea nitrogen; Cre: creatinine.